Atorvastatin protects the proliferative ability of human umbilical vein endothelial cells inhibited by angiotensin II by changing mitochondrial energy metabolism

Chang,Ye; Li,Yuan; Ye,Ning; Guo,Xiaofan; Li,Zhao; Sun,Guozhe; Sun,Yingxian

doi:10.3892/ijmm.2017.3200

Atorvastatin protects the proliferative ability of human umbilical vein endothelial cells inhibited by angiotensin II by changing mitochondrial energy metabolism

Authors:
- Ye Chang
- Yuan Li
- Ning Ye
- Xiaofan Guo
- Zhao Li
- Guozhe Sun
- Yingxian Sun
View Affiliations

Affiliations: Department of Cardiology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China
Published online on: October 19, 2017 https://doi.org/10.3892/ijmm.2017.3200
Pages: 33-42
Copyright: © Chang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study aimed to explore whether angiotensin II (Ang II) inhibits the proliferation of human umbilical vein endothelial cells (HUVECs) by changing mitochondrial energy metabolism, and whether atorvastatin has a protective role via restoration of endothelial function. HUVECs were treated with 1 µM Ang II alone or with 10 µM atorvastatin for 24 h. Proliferation was detected by MTT assay, cell counting, 5‑ethynyl‑2'‑deoxyuridine assay and real‑time cell analyzer. Mitochondrial energy metabolism including oxygen consumption rate and extracellular acidification rate were measured using a Seahorse metabolic flux analyzer. Mitochondrial membrane potential was detected under fluorescence microscope following staining with tetramethylrhodamine. Respiratory chain complexes I‑V were detected using western blotting. The current study showed that Ang II inhibits the proliferation of HUVECs. Results from the Seahorse metabolic flux analyzer indicated that Ang II decreased basal oxygen consumption, maximal respiration capacity, spare respiration capacity, adenosine triphosphate‑linked respiration and non‑mitochondrial respiration. By contrast, Ang II increased the proton leak. Additionally, Ang II increased glycolysis, glycolytic capacity and non‑glycolytic acidification. Furthermore, these effects were all suppressed by atorvastatin. The results indicated that atorvastatin prevents cellular energy metabolism switching from oxidative phosphorylation to glycolysis induced by Ang II and protected the proliferative ability of HUVECs.

View Figures

View References

1	Whaley-Connell A, Johnson MS and Sowers JR: Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis. 52:401–409. 2010. View Article : Google Scholar : PubMed/NCBI
2	Aroor AR, Demarco VG, Jia G, Sun Z, Nistala R, Meininger GA and Sowers JR: The role of tissue renin-angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front Endocrinol Lausanne: 4. pp. 1612013, View Article : Google Scholar
3	Schiffrin EL and Touyz RM: From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol. 287:H435–H446. 2004. View Article : Google Scholar : PubMed/NCBI
4	Touyz RM: The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep. 5:155–164. 2003. View Article : Google Scholar : PubMed/NCBI
5	Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R and Unger T: The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 95:651–657. 1995. View Article : Google Scholar : PubMed/NCBI
6	Sata M and Fukuda D: Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J Med Invest. 57:12–25. 2010. View Article : Google Scholar : PubMed/NCBI
7	Hill BG, Dranka BP, Zou L, Chatham JC and Darley-Usmar VM: Importance of the bioenergetic reserve capacity in response to cardiomyocyte stress induced by 4-hydroxynonenal. Biochem J. 424:99–107. 2009. View Article : Google Scholar : PubMed/NCBI
8	Ballinger SW: Mitochondrial dysfunction in cardiovascular disease. Free Radic Biol Med. 38:1278–1295. 2005. View Article : Google Scholar : PubMed/NCBI
9	Madamanchi NR and Runge MS: Mitochondrial dysfunction in atherosclerosis. Circ Res. 100:460–473. 2007. View Article : Google Scholar : PubMed/NCBI
10	Ryan MT and Hoogenraad NJ: Mitochondrial-nuclear communications. Annu Rev Biochem. 76:701–722. 2007. View Article : Google Scholar : PubMed/NCBI
11	Picard M, Taivassalo T, Gouspillou G and Hepple RT: Mitochondria: isolation, structure and function. J Physiol. 589:4413–4421. 2011. View Article : Google Scholar : PubMed/NCBI
12	Dranka BP, Hill BG and Darley-Usmar VM: Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic Biol Med. 48:905–914. 2010. View Article : Google Scholar : PubMed/NCBI
13	Davignon J: Beneficial cardiovascular pleiotropic effects of statins. Circulation. 109(Suppl 1): III39–III43. 2004. View Article : Google Scholar : PubMed/NCBI
14	Guimarães DA, Rizzi E, Ceron CS, Pinheiro LC, Gerlach RF and Tanus-Santos JE: Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension. Redox Biol. 1:578–585. 2013. View Article : Google Scholar : PubMed/NCBI
15	Zhou MS, Tian R, Jaimes EA and Raij L: Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension. Am J Hypertens. 27:873–880. 2014. View Article : Google Scholar : PubMed/NCBI
16	Ma Y, Chen Z, Zou Y and Ge J: Atorvastatin represses the angiotensin 2-induced oxidative stress and inflammatory response in dendritic cells via the I3K/Akt/Nrf2 pathway. Oxid Med Cell Longev. 148798:2014. View Article : Google Scholar
17	Chen S, Liu B, Kong D, Li S, Li C, Wang H and Sun Y: Atorvastatin calcium inhibits phenotypic modulation of PDGF-BB-induced VSMCs via down-regulation the Akt signaling pathway. PLoS One. 10:e01225772015. View Article : Google Scholar : PubMed/NCBI
18	Ke N, Wang X, Xu X and Abassi YA: The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol. 740:33–43. 2011. View Article : Google Scholar : PubMed/NCBI
19	Ma M, Guo X, Chang Y, Li C, Meng X, Li S, Du ZX, Wang HQ and Sun Y: Advanced glycation end products promote proliferation and suppress autophagy via reduction of cathepsin D in rat vascular smooth muscle cells. Mol Cell Biochem. 403:73–83. 2015. View Article : Google Scholar : PubMed/NCBI
20	Li Z, Berk M, McIntyre TM, Gores GJ and Feldstein AE: The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology. 47:1495–1503. 2008. View Article : Google Scholar : PubMed/NCBI
21	Gottlieb E, Armour SM, Harris MH and Thompson CB: Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ. 10:709–717. 2003. View Article : Google Scholar : PubMed/NCBI
22	Lei T, Guo N, Tan MH and Li YF: Effect of mouse oocyte vitrification on mitochondrial membrane potential and distribution. J Huazhong Univ Sci Technolog Med Sci. 34:99–102. 2014. View Article : Google Scholar : PubMed/NCBI
23	Hill BG, Higdon AN, Dranka BP and Darley-Usmar VM: Regulation of vascular smooth muscle cell bioenergetic function by protein glutathiolation. Biochim Biophys Acta. 1797:285–295. 2010. View Article : Google Scholar :
24	Alvarez E, Rodiño-Janeiro BK, Ucieda-Somoza R and González-Juanatey JR: Pravastatin counteracts angiotensin II-induced upregulation and activation of NADPH oxidase at plasma membrane of human endothelial cells. J Cardiovasc Pharmacol. 55:203–212. 2010. View Article : Google Scholar
25	Ferrick DA, Neilson A and Beeson C: Advances in measuring cellular bioenergetics using extracellular flux. Drug Discov Today. 13:268–274. 2008. View Article : Google Scholar : PubMed/NCBI
26	Sansbury BE, Jones SP, Riggs DW, Darley-Usmar VM and Hill BG: Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. Chem Biol Interact. 191:288–295. 2011. View Article : Google Scholar :
27	Li P, Guo X, Lei P, Shi S, Luo S and Cheng X: I3K/Akt/uncoupling protein 2 signaling pathway may be involved in cell senescence and apoptosis induced by angiotensin II in human vascular endothelial cells. Mol Biol Rep. 41:6931–6937. 2014. View Article : Google Scholar : PubMed/NCBI
28	Eelen G, de Zeeuw P, Simons M and Carmeliet P: Endothelial cell metabolism in normal and diseased vasculature. Circ Res. 116:1231–1244. 2015. View Article : Google Scholar : PubMed/NCBI
29	Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, La Grenade L, Gurwitz JH, Chan KA, Goodman MJ and Platt R: Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. 292:2585–2590. 2004. View Article : Google Scholar : PubMed/NCBI
30	Sathasivam S: Statin induced myotoxicity. Eur J Intern Med. 23:317–324. 2012. View Article : Google Scholar : PubMed/NCBI
31	Mabuchi H, Higashikata T, Kawashiri M, Katsuda S, Mizuno M, Nohara A, Inazu A, Koizumi J and Kobayashi J: Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients. J Atheroscler Thromb. 12:111–119. 2005. View Article : Google Scholar : PubMed/NCBI
32	Vaughan RA, Garcia-Smith R, Bisoffi M, Conn CA and Trujillo KA: Ubiquinol rescues simvastatin-suppression of mitochondrial content, function and metabolism: implications for statin-induced rhabdomyolysis. Eur J Pharmacol. 711:1–9. 2013. View Article : Google Scholar : PubMed/NCBI
33	Mullen PJ, Zahno A, Lindinger P, Maseneni S, Felser A, Krähenbühl S and Brecht K: Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt. Biochim Biophys Acta. 1813:2079–2087. 2011. View Article : Google Scholar : PubMed/NCBI
34	Carnicka S, Adameova A, Nemcekova M, Matejikova J, Pancza D and Ravingerova T: Distinct effects of acute pretreatment with lipophilic and hydrophilic statins on myocardial stunning, arrhythmias and lethal injury in the rat heart subjected to ischemia/reperfusion. Physiol Res. 60:825–830. 2011.PubMed/NCBI